Let’s start up with the current stock price of GenMark Diagnostics Inc. (GNMK), which is $23.99 to be very precise. The Stock rose vividly during the last session to $24.0079 after opening rate of $23.96 while the lowest price it went was recorded $23.95 before closing at $23.89.
Recently in News on April 13, 2021, INVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm. Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:. You can read further details here
GenMark Diagnostics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $24.25 on 03/26/21, with the lowest value was $12.76 for the same time period, recorded on 01/29/21.
GenMark Diagnostics Inc. (GNMK) full year performance was 286.94%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, GenMark Diagnostics Inc. shares are logging -1.07% during the 52-week period from high price, and 323.85% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $5.66 and $24.25.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4301135 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the GenMark Diagnostics Inc. (GNMK) recorded performance in the market was 64.32%, having the revenues showcasing 54.97% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.76B, as it employees total of 618 workers.
The Analysts eye on GenMark Diagnostics Inc. (GNMK)
During the last month, 0 analysts gave the GenMark Diagnostics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 17.52, with a change in the price was noted +10.43. In a similar fashion, GenMark Diagnostics Inc. posted a movement of +76.92% for the period of last 100 days, recording 2,050,312 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GNMK is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.76.
Technical rundown of GenMark Diagnostics Inc. (GNMK)
Raw Stochastic average of GenMark Diagnostics Inc. in the period of last 50 days is set at 97.56%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 36.59%. In the last 20 days, the company’s Stochastic %K was 50.85% and its Stochastic %D was recorded 72.50%.
Considering, the past performance of GenMark Diagnostics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 64.32%. Additionally, trading for the stock in the period of the last six months notably improved by 70.02%, alongside a boost of 286.94% for the period of the last 12 months. The shares increased approximately by -0.04% in the 7-day charts and went down by 29.68% in the period of the last 30 days. Common stock shares were driven by 54.97% during last recorded quarter.